Sara G Danielli

Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance

P. Bühlmann, H. Blau, D. Surdez, 2023, Science advances.

Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma

B. Schäfer, Elizabeth Stewart, D. Langenau, 2023, bioRxiv.

PAX3-FOXO1 uses its activation domain to recruit CBP/P300 and shape RNA Pol2 cluster distribution

Richard C. Sallari, B. Schäfer, Q. Ngo, 2023, Nature communications.

Single-cell mapping of tumor heterogeneity in pediatric rhabdomyosarcoma reveals developmental signatures with therapeutic relevance

P. Bühlmann, H. Blau, B. Schäfer, 2022, bioRxiv.

Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma

B. Schäfer, J. Shipley, R. Alaggio, 2023, Cancers.